Registry for patients with venous blood clots

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) aims to create a comprehensive database of patients diagnosed with venous thromboembolism (VTE). This observational project collects data on various patient subgroups often excluded from clinical trials, such as pregnant women and those with severe comorbidities. By analyzing this data, the registry seeks to enhance physician understanding of VTE management and develop predictive scores for identifying high-risk patients. The goal is to reduce mortality and complications associated with thromboembolic events.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed VTE (acute deep-vein thrombosis, pulmonary embolism and/or superficial venous thrombosis) by objective tests.
* Informed consent to the participation in the study, according to the requirements of the ethics committee within each hospital.

Exclusion Criteria:

* Participation in a therapeutic clinical trial with an unknown drug.
* Inability to the 3 month follow-up

Where it's running

• College of Medicine - Jacksonville University of Florida
  Jacksonville, Florida, United States Recruiting
• Evanston NorthShore University HealthSystem
  Evanston, Illinois, United States Recruiting
• Massachusetts General Hospital
  Boston, Massachusetts, United States Recruiting
• Medical University of Vienna
  Vienna, State of Vienna, Austria Recruiting
• Hospital UZ Leuven
  Leuven, Leuven, Belgium Recruiting
• Hospital Cardio Pulmonar
  Salvador, Salvador, Brazil Recruiting

+255 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Mayra Hawkins
• Email: riete@shmedical.es
• Phone: 0034915357183

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DoACs vs LMWH for blood flow after knee replacement

  This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.

  Recruiting Military Hospital of Tunis · Tunis, Tunis Governorate · NCT07869615

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Screening for blood clots in adults with acute heart failure

  This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.

  Recruiting University Hospital, Angers · Agen and 9 other locations · NCT07499661

• Blood test and software to guide treatment for venous thromboembolism

  This project tests whether a blood-based ctDNA test combined with a software risk score can predict if VTE will come back in adults with cancer-associated DVT or PE who have finished 3–12 months of anticoagulation.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT07399977

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

• Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism

  This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.

  Recruiting University Hospital, Brest · Brest · NCT07328152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.